Search Within

Gastrointestinal Oncology Service

Formats
  1. Journal Article (2349)
  2. Meeting Abstract (1870)
  3. Review (150)
  4. Book Section (127)
  5. Editorial (100)
  6. Guidelines (39)
  7. Correspondence (34)
  8. Conference Paper (24)
  9. Miscellaneous (22)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Solid Tumor Oncology Division (4744)
  2. Department of Medicine (4742)
  3. Center for Pancreatic Cancer Research (2312)
  4. Surgery (1065)
  5. Survivorship Research (1013)
  6. Epidemiology and Biostatistics (842)

More Groups

People
  1. Eileen O'Reilly (803)
  2. Leonard Saltz (796)
  3. Ghassan Abou-Alfa (583)
  4. Nancy Kemeny (545)
  5. David Kelsen (538)
  6. David Ilson (443)

More People

Years
  1. 2025 (219)
  2. 2024 (309)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1290)
  2. Annals of Oncology (331)
  3. Annals of Surgical Oncology (147)
  4. Cancer (128)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1379)
  2. Oxford University Press (462)
  3. Elsevier Inc. (408)
  4. Springer (320)
  5. American Association for Cancer Research (281)
  6. Wiley Blackwell (241)

More Publishers

Results (4744)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Zolbetuximab + CAPOX versus CAPOX in first-line treatment of claudin18.2(+)/HER2(-) advanced/metastatic gastric or gastroesophageal junction adenocarcinoma: GLOW phase 3 study
    Meeting Abstract

    Shah, M. A.; Ajani, J. A.; Al-Batran, S. E.; Bang, Y. J.; Catenacci, D. V. T.; Enzinger, P. C.; Ilson, D. H.; Kim, S. S.; Lordick, F.; Shitara, K.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Nivolumab (NIVO) plus chemotherapy (chemo) versus chemo as first-line (1L) treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): Expanded efficacy, safety, and subgroup analyses from CheckMate 649
    Meeting Abstract

    Shitara, K.; Janjigian, Y. Y.; Moehler, M. H.; Garrido, M.; Gallardo, C.; Shen, L.; Yamaguchi, K.; Wyrwicz, L.; Skoczylas, T.; Bragagnoli, C. A. S.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Number needed to treat (NNT) analysis of patients in CheckMate 649 (CM 649): Nivolumab plus chemotherapy versus chemotherapy as first-line (1L) treatment for advanced gastric cancer, gastroesophageal junction cancer, and esophageal adenocarcinoma (GC/GEJ/EAC)
    Meeting Abstract

    Sugarman, R.; Nunna, S.; Betts, K. A.; Nie, X.; Nguyen, H.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • A quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis of patients in CheckMate 649: Nivolumab plus chemotherapy versus chemotherapy as first-line treatment for advanced gastric cancer/gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC)
    Meeting Abstract

    Sugarman, R.; Botteman, M.; Rusibamayila, N.; Nguyen, H.; Lin, D.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Brain metastasis in gastroesophageal adenocarcinoma: Outcomes and molecular features
    Meeting Abstract

    Tsai, C.; Nguyen, B.; Luthra, A.; Chou, J. F.; Tang, L. H.; Strong, V. E.; Molena, D.; Jones, D. R.; Coit, D. G.; Ilson, D. H.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Randomized phase II trial of postoperative adjuvant capecitabine and temozolomide versus observation in high-risk pancreatic neuroendocrine tumors: SWOG S2104
    Meeting Abstract

    Soares, H. P.; Guthrie, K. A.; Ahmad, S. A.; Washington, M. K.; Ramnaraign, B. H.; Raj, N. P.; Seigel, C.; Bellasea, S.; Chiorean, E. G.; Dasari, A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Distinct differences in genomic profile of gastric and gastroesophageal junction adenocarcinoma
    Meeting Abstract

    Nakauchi, M.; Walch, H. S.; Chatila, W. K.; Tran, T.; Vos, E. L.; Sihag, S.; Tang, L. H.; Coit, D. G.; Stadler, Z. K.; Janjigian, Y. Y.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Salvage ablative radiation therapy for loco-regionally recurrent pancreatic ductal adenocarcinoma following surgical resection
    Meeting Abstract

    Ng, V.; Zinovoy, M.; Hajj, C.; Romesser, P. B.; Wu, A. J. C.; Cuaron, J. J.; Jarnagin, W. R.; O'Reilly, E. M.; Crane, C. H.; Reyngold, M.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • The immune impact of PI3K-AKT pathway inhibition in colorectal cancer
    Meeting Abstract

    Nusrat, M.; Syed, M. A.; Katkhuda, R.; Parra, E. R.; Wistuba, I. I.; Kong, P.; Koehne, A.; Dasari, A.; Overman, M. J.; Menter, D.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Early-onset well differentiated pancreatic neuroendocrine tumors: Clinical presentation, pathologic features, and oncological outcomes
    Meeting Abstract

    Pulvirenti, A.; Hauser, H.; Le, T.; McIntyre, C. A.; Reidy, D. L.; Wei, A. C. C.; Raj, N. P.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save